Company intelligence / Profile preview

Cappella Medical Devices

Galway, Ireland

Ownership: Private
Development stage: Other

Overview

Cappella's Sideguard coronary sidebranch stent system has been successfully deployed in real-world clinical settings. A prospective study of 20 consecutive patients demonstrated successful use in all cases, including technically difficult bifurcation lesions, with the device achieving full ostial coverage through its novel trumpet-shaped design[6].

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Cappella Medical Devices.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cappella Medical Devices.

Explore the full profile